Skip to main content

Animations

MJFF Publications

8341 - 8350 of 9030 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2016
  • 2020
  • 2023
  • 2022
  • 2025
  • 2025
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.70672
    Citation Count: 0
  • Carrying on a Father's Legacy
    2025
    Summary Details
    RESTRICTED
    Title: Carrying on a Father's Legacy
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0001125860.72537.e7
    Citation Count: 0
  • Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease
    2016
    Summary Details
    RESTRICTED
    Title: Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.04.023
    Citation Count: 54
  • Summary Details
    OPEN
    Title: A Failed Future
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1002/mds.28130
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice
    Journal Name: Advanced Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/adbi.202300154
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2022.102733
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro Characterization, and In Vivo PET Neuroimaging of [18F]F-4 for Tau Protein: A First-in-Human PET Study
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00866
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41467-025-66146-4
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.338
    Citation Count: 611
  • Summary Details
    OPEN
    Title: 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00551-x
    Citation Count: 59
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.